CAS No. |
2084828-53-3 |
中文名称 |
噻唑-5-基甲基((5S,6S,8S,12S,15S,17S,18S)-5,8,15-三苄基-6,17-二羟基-12-异丙基-3,10,13-三氧代-19-苯基-1-(噻唑-5-基)-2-氧杂-4,9,11,14-四氮杂十九烷-18-基)氨基甲酸酯 |
英文名称 |
Thiazol-5-ylmethyl ((5S,6S,8S,12S,15S,17S,18S)-5,8,15-tribenzyl-6,17-dihydroxy-12-isopropyl-3,10,13-trioxo-19-phenyl-1-(thiazol-5-yl)-2-oxa-4,9,11,14-tetraazanonadecan-18-yl)carbamate |
别名 |
UFFLDXFQXNYZLF-BHRSBNONSA-N;Ritonavir Impurity 19;Ritonavir Impurity S;Thiazol-5-yl-methyl [(1S,2S,4S)-1-benzyl-4-[[(2S)-2[[[(1S,3S,4S)-1-benzyl-3-hydroxy-5-phenyl-4-[[(thiazol-5-ylmethoxy)carbonyl]amino]pentyl]carbamoyl] amino]-3-methylbutanoyl]amino]-2-hydroxy-5-phenylpentyl]carbamate;Ritonavir impurity reference ep-S;Ritonavir EP impurity S (Ritonavir?Impurity);2,7,9,12,17-Pentaazaoctadecanedioic acid, 4,15-dihydroxy-10-(1-methylethyl)-8,11-dioxo-3,6,13,16-tetrakis(phenylmethyl)-, 1,18-bis(5-thiazolylmethyl) ester, (3S,4S,6S,10S,13S,15S,16S)-;RITOVIR IMPURITY S |
标准英文名 |
thiazol-5-ylmethyl ((5S,6S,8S,12S,15S,17S,18S)-5,8,15-tribenzyl-6,17-dihydroxy-12-isopropyl-3,10,13-trioxo-19-phenyl-1-(thiazol-5-yl)-2-oxa-4,9,11,14-tetraazanonadecan-18-yl)carbamate |
分子式 |
C52H61N7O8S2 |
分子量 |
976.23
|
精确分子量 |
975.40
|
SMILES |
O=C(OCC1=CN=CS1)N[C@@H](CC2=CC=CC=C2)[C@@H](O)C[C@H](CC3=CC=CC=C3)NC([C@H](C(C)C)NC(N[C@@H](CC4=CC=CC=C4)C[C@H](O)[C@H](CC5=CC=CC=C5)NC(OCC6=CN=CS6)=O)=O)=O |
标准SMILES |
CC(C)[C@H](NC(=O)N[C@H](C[C@H](O)[C@H](CC1=CC=CC=C1)NC(=O)OCC1=CN=CS1)CC1=CC=CC=C1)C(=O)N[C@H](C[C@H](O)[C@H](CC1=CC=CC=C1)NC(=O)OCC1=CN=CS1)CC1=CC=CC=C1 |
InChIKey |
UFFLDXFQXNYZLF-BHRSBNONSA-N |